Cargando…
Neonatal Cardiovascular Function after Antenatal Sildenafil for Severe, Early-Onset Intrauterine Growth Restriction: A Substudy of the STRIDER-NZAus Randomized Placebo-Controlled Trial
We evaluated the effect of antenatal sildenafil on neonatal cardiovascular function in a subgroup of 27 infants of mothers participating in the STRIDER-NZAus randomized controlled trial. In this small study, we found no association between antenatal sildenafil and neonatal cardiac dysfunction includ...
Autores principales: | Harris, Sarah L., McKinlay, Chris, Groom, Katie, Beker, Friederike, Kochar, Anuradha, Gill, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236542/ https://www.ncbi.nlm.nih.gov/pubmed/37333836 http://dx.doi.org/10.1016/j.ympdx.2019.100009 |
Ejemplares similares
-
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials
por: Pels, A., et al.
Publicado: (2017) -
Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction
por: Pels, Anouk, et al.
Publicado: (2019) -
STRIDER: Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction – a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis
por: Ganzevoort, Wessel, et al.
Publicado: (2014) -
Halting the Canadian STRIDER randomised controlled trial of sildenafil for severe, early-onset fetal growth restriction: ethical, methodological, and pragmatic considerations
por: von Dadelszen, Peter, et al.
Publicado: (2022) -
Intrauterine Growth Restriction: Antenatal and Postnatal Aspects
por: Sharma, Deepak, et al.
Publicado: (2016)